Previous close | 3.2200 |
Open | 3.2500 |
Bid | 3.2200 x 400 |
Ask | 3.2500 x 200 |
Day's range | 3.1850 - 3.2550 |
52-week range | 1.9600 - 4.7050 |
Volume | |
Avg. volume | 1,152,580 |
Market cap | 429.533M |
Beta (5Y monthly) | 1.65 |
PE ratio (TTM) | 81.00 |
EPS (TTM) | 0.0400 |
Earnings date | 08 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.38 |
We recently compiled a list of the 10 Best NASDAQ Penny Stocks To Invest In. In this article, we are going to take a look at where Organogenesis Holdings Inc. (NASDAQ:ORGO) stands against the other NASDAQ penny stocks. Penny stocks are companies that are trading under $5 per share. They represent a unique and controversial […]
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that second quarter of fiscal year 2024 financial results will be reported after the market closes on Thursday, August 8th. Management will host a conference call at 5:00 p.m. Eastern Time on August
Organogenesis Holdings' (NASDAQ:ORGO) stock is up by a considerable 11% over the past month. As most would know...